retinopathy đái tháo đường

Fenofibrate Use and Reduced Risk of Sight-Threatening Diabetic Retinopathy in Type 2 Diabetes: Insights from UK Real-World Data

By MedXY 09/18/2026

Fenofibrate use in type 2 diabetes patients is associated with a significant reduction in the risk of sight-threatening diabetic retinopathy compared to statins, based on UK primary care data over 12 years.

Diabetes & Endocrinology news Ophthalmology

Common Anti-Inflammatory Drugs Linked to Lower Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes

By MedXY 09/14/2026

A large retrospective cohort study suggests that cetirizine, ibuprofen, and prednisone use in adults with type 2 diabetes is associated with significantly reduced incidence of diabetic macular edema and proliferative diabetic retinopathy, highlighting anti-inflammatory pathways as potential targets for prevention.

Diabetes & Endocrinology news Ophthalmology

Impact of Neighborhood Socioeconomic Deprivation on Diabetic Retinopathy Screening Adherence in Medicare Beneficiaries

By MedXY 09/01/2026

Increasing neighborhood socioeconomic deprivation is associated with reduced adherence to annual diabetic retinopathy screening among Medicare patients, highlighting disparities in preventive eye care.

Diabetes & Endocrinology news Ophthalmology

Gene-Lifestyle Synergy in Diabetic Retinopathy Development

By MedXY 08/23/2026

This study reveals how genetic risk for diabetic retinopathy can be significantly mitigated by healthy lifestyle choices, emphasizing universal behavioral interventions for prevention.

Clinical Updates Diabetes & Endocrinology news Ophthalmology

Baseline Deep Capillary Plexus Ischemia as a Superior Predictor of Early Diabetic Retinopathy Complications Relative to Foveal Avascular Zone Enlargement

By MedXY 08/16/2026

Deep capillary plexus ischemia quantified by geometric perfusion deficit predicts earlier and higher risk of diabetic retinopathy complications than foveal avascular zone enlargement, underscoring GPDd's clinical utility as a biomarker for personalized monitoring.

AI Diabetes & Endocrinology news Ophthalmology

Comparative Performance of Four AI Systems for Detecting Referable Diabetic Retinopathy in Tanzania: A Real-World Evaluation

By MedXY 08/12/2026

This study evaluates four commercially available AI systems for diabetic retinopathy screening in Tanzania, demonstrating high sensitivity for referable and proliferative DR and highlighting considerations for implementation in low-resource settings.

Diabetes & Endocrinology news Ophthalmology

Systemic Interleukin-6 Inhibition as a Novel Approach to Reduce Diabetic Retinopathy Risk and Progression

By MedXY 08/06/2026

Systemic IL-6 inhibitors are linked to significantly reduced risks of diabetic retinopathy development, progression, and vision-threatening complications, suggesting therapeutic potential for diabetic eye disease.

Diabetes & Endocrinology news Ophthalmology

Bridging the Gap: Geographic Disparities in Access to Diabetic Retinopathy Care Across the United States

By MedXY 07/17/2026

This study reveals significant urban-rural disparities in access to diabetic retinopathy diagnostic and therapeutic services in the U.S., underscoring the need for targeted strategies to improve care in non-urban areas.

Diabetes & Endocrinology news Ophthalmology

Hyperreflective Abnormal Areas in Middle Retinal Layers via En Face OCT: A Novel Biomarker for Diabetic Retinopathy Risk Stratification

By MedXY 07/15/2026

Hyperreflective abnormalities in middle retinal layers detected by en face OCT improve diagnostic discrimination of referable diabetic retinopathy, offering a promising adjunct biomarker beyond clinical parameters.

Diabetes & Endocrinology news Ophthalmology

Blood Pressure Assessment in Ophthalmology Clinics for Patients With Diabetes: A Case Series Analysis

By MedXY 07/09/2026

This case series reveals a high prevalence of uncontrolled hypertension among diabetic patients visiting ophthalmology clinics and highlights the importance of in-clinic blood pressure screening to identify and manage cardiovascular risk.

Clinical Updates news

Integrated Intraocular and Plasma Proteomics Identify Neurofilament Light Chain as a Conserved Biomarker for Diabetic Retinopathy Progression: A Multi-Fluid Biopsy Perspective

By MedXY 07/01/2026

This review synthesizes evidence on neurofilament light chain (NFL) as a minimally invasive plasma biomarker predictive of diabetic retinopathy progression and vascular complications, based on integrated intraocular-plasma proteomics and multi-cohort validations.

Diabetes & Endocrinology news Ophthalmology

Poor Glycemic Control and Higher Blood Pressure Track With Early Diabetic Retinal Disease in Youth With Type 1 Diabetes

By MedXY 06/08/2026

A large retrospective study links higher HbA1c and elevated blood pressure to diabetic retinopathy in youth with type 1 diabetes, while worse glycemia also correlates with thinner inner retinal layers suggestive of early neurodegeneration.

Clinical Updates Diabetes & Endocrinology news Ophthalmology

Glucagon-Like Peptide-1 Receptor Agonists and Vascular Protection: Mitigating Systemic and Ocular Risks in High-Risk Type 2 Diabetes

By MedXY 04/27/2026

A large-scale cohort study demonstrates that GLP-1 RAs significantly reduce macrovascular and microvascular complications, including proliferative retinopathy and retinal vein occlusion, in patients with pre-existing diabetic retinopathy.

Diabetes & Endocrinology news Ophthalmology

Diabetic Retinopathy Severity Predicts Mortality Risk: Insights from the SOURCE Consortium

By MedXY 04/11/2026

A retrospective cohort study of 524,687 diabetic patients reveals that increasing severity of diabetic retinopathy correlates with significantly higher mortality risk, with proliferative DR patients showing a 128% increased hazard of death compared to diabetics without retinopathy.

Diabetes & Endocrinology news Ophthalmology

Deep Capillary Plexus Defects Emerge as a Universal Biomarker for Retinal Ischemia Across All Retinal Regions in Diabetic Retinopathy

By MedXY 04/02/2026

Novel OCTA biomarkers reveal that geometric perfusion deficits in the deep capillary plexus serve as robust predictors of retinal nonperfusion across posterior, peripheral, and total retinal regions, while foveal avascular zone enlargement specifically reflects posterior ischemic changes in diabetes.

Diabetes & Endocrinology news Ophthalmology

Evening Chronotype Linked to Progression of Diabetic Retinopathy and Poor Metabolic Control

By MedXY 02/03/2026

Recent longitudinal and cross-sectional data reveal that patients with an evening chronotype face significantly higher risks of diabetic retinopathy and metabolic dysregulation, independent of traditional glycemic markers like HbA1c.

Diabetes & Endocrinology news Ophthalmology

Quantitative Retinal Leakage on Ultra-Widefield Imaging: A New Biomarker for Predicting Diabetic Retinopathy Progression

By MedXY 01/30/2026

A post hoc analysis of the DRCR Retina Network Protocol AA reveals that automated quantitative leakage index on ultra-widefield fluorescein angiography independently predicts the 4-year risk of DRSS worsening and vision-threatening complications in patients with nonproliferative diabetic retinopathy.

Diabetes & Endocrinology news Ophthalmology Pathology & Lab Medicine

Indole-3-Propionic Acid Bridges Gut Dysfunction and Diabetic Retinopathy — A Biomarker and Therapeutic Avenue

By MedXY 11/09/2025

A Gut 2025 study identifies microbially produced indole-3-propionic acid (IPA) as a protective metabolite linking restored intestinal tryptophan handling to prevention of diabetic retinopathy in mice and associates low serum IPA with retinopathy in people with type 2 diabetes.

Diabetes & Endocrinology news Ophthalmology

Long-Term Progression and Risk Factors of Diabetic Retinopathy in Type 2 Diabetes: Insights from the Skaraborg Cohort in Sweden

By MedXY 10/31/2025

This cohort study tracks diabetic retinopathy incidence over 24 years in type 2 diabetes patients, highlighting the impact of glycemic control and hypertension on disease progression.